The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
about
Adverse effects of biologics: a network meta-analysis and Cochrane overviewAnakinra for rheumatoid arthritisSafety of extended treatment with anakinra in patients with rheumatoid arthritisBiologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project.Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow.Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.Infectious complications associated with monoclonal antibodies and related small moleculesInflammasome Activation Can Mediate Tissue-Specific Pathogenesis or Protection in Staphylococcus aureus Infection.Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis.Cardiovascular safety of biologic therapies for the treatment of RA.Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocAnakinra in the treatment of rheumatic disease.Sarcoid-like granulomatosis in a patient treated by interleukin-1 receptor antagonist for TNF-receptor-associated periodic syndrome.
P2860
Q24234197-6ACC6594-4185-4B07-8C19-8F0DC30AA58FQ24241707-49043324-1D30-419A-A623-358EC1991374Q24675209-2A36C004-09BC-463F-8444-976FD6F3900CQ30234528-D85FF546-126D-4394-AF6B-75D57FED07D5Q33315300-634E56D8-C777-4C60-8795-10C05177E09BQ33369142-668D5F9C-90D1-4429-9305-4CE7A04E9E7AQ33573112-9CE6162B-A288-4AEE-868A-24016B675A73Q33962865-7F6706B7-7450-48F6-B740-51CC47F4ABD1Q34896866-68E42768-BA96-4200-955D-0F43BD948EA4Q36195284-9FAA5464-AE0D-4E9B-AC71-FF1D771C07B6Q36289418-EE129E4D-B7F0-4321-88A0-A2C9C3557506Q37156636-97794726-BD5F-437A-BEB2-995E2E8A4914Q37486275-D04B7E80-E11A-48BD-B7F6-A2197430FC3AQ37728019-D44F6998-E3D0-44B6-B13F-22A660968D3DQ37956137-336F7406-F6E2-4470-90F6-22443586F6CAQ38993250-45E354AA-6334-425B-9B56-79AD52DDC93DQ41581182-95C13967-4DA6-4646-8F01-B54E1C2308EFQ43061720-D37A0C70-7B60-417A-BF96-73118CD135ADQ45759169-AD492248-0EA5-4556-B88F-0FD1F945DD8E
P2860
The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The safety of anakinra in high ...... ents with comorbid conditions.
@en
The safety of anakinra in high ...... ents with comorbid conditions.
@nl
type
label
The safety of anakinra in high ...... ents with comorbid conditions.
@en
The safety of anakinra in high ...... ents with comorbid conditions.
@nl
prefLabel
The safety of anakinra in high ...... ents with comorbid conditions.
@en
The safety of anakinra in high ...... ents with comorbid conditions.
@nl
P2093
P356
P1476
The safety of anakinra in high ...... ents with comorbid conditions.
@en
P2093
Alan M Solinger
Gino DiVittorio
John Tesser
Joy Schechtman
Michael H Schiff
Roy Fleischmann
Sanford Hartman
Thomas Liu
P304
P356
10.1002/ART.20277
P577
2004-06-01T00:00:00Z